Single Domain Antibody Platform Market to Reach US$ 86 Million by 2034, Expanding at a CAGR of 10.1% | Fact.MR Report [Yahoo! Finance]
OmniAb, Inc. (OABI)
Company Research
Source: Yahoo! Finance
Rockville, MD, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Increasing investments in healthcare research and development are leading to the increased adoption of single domain antibody platforms due to their key role in improving the efficacy of treatments. The global single domain antibody platform market is estimated to reach a market value of US$ 32.9 million in 2024 and further advance at 10.1% CAGR from 2024 to 2034. There are several key factors contributing to the significant growth of the single-domain antibody platform market. Technological advancements are leading to the development of creative single-domain antibody platform solutions that meet a range of customer needs in various industries. In addition to acquisitions and partnerships, the market is witnessing inorganic growth strategies like partnerships and collaborations. Growing demand for single domain antibody platforms is due to their efficacy in diverse diseases, low immunogenicity, customizable engineering, cost effic
Show less
Read more
Impact Snapshot
Event Time:
OABI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OABI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OABI alerts
High impacting OmniAb, Inc. news events
Weekly update
A roundup of the hottest topics
OABI
News
- OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics ConferenceBusiness Wire
- OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]Yahoo! Finance
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.MarketBeat
- OmniAb Inc (OABI) Q3 2024 Earnings Call Highlights: Strong Program Growth Amid Revenue Challenges [Yahoo! Finance]Yahoo! Finance
OABI
Earnings
- 11/12/24 - Miss
OABI
Sec Filings
- 12/10/24 - Form 4
- 12/10/24 - Form 4
- 12/10/24 - Form 4
- OABI's page on the SEC website